Avectas, UCD partner on cell engineering

By The Science Advisory Board staff writers

June 3, 2020 -- Avectas and the Simon Laboratory at UC Davis, California (UCD) will work together on cell-engineering technology.

UCD will characterize engineered cells with Avectas' nonviral cell-engineering platform Solupore to inform the development of next-generation cell and gene therapies.

Avectas' platform will be transferred to the Simon Laboratory where they will engineer immune cells and study the delivery of cargoes, like DNA, mRNA, and proteins. They hope the collaboration will aid in the development of new cell and gene therapies.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here